GB1239073A - - Google Patents
Info
- Publication number
- GB1239073A GB1239073A GB1239073DA GB1239073A GB 1239073 A GB1239073 A GB 1239073A GB 1239073D A GB1239073D A GB 1239073DA GB 1239073 A GB1239073 A GB 1239073A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxido
- acetoxy
- oxo
- androstan
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 abstract 2
- DJPZSBANTAQNFN-UHFFFAOYSA-N Testosterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(OC(=O)C)C1(C)CC2 DJPZSBANTAQNFN-UHFFFAOYSA-N 0.000 abstract 1
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 abstract 1
- KPCDGGNHYODURF-PXQJOHHUSA-N [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 KPCDGGNHYODURF-PXQJOHHUSA-N 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- DJPZSBANTAQNFN-PXQJOHHUSA-N testosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 DJPZSBANTAQNFN-PXQJOHHUSA-N 0.000 abstract 1
- 125000005580 triphenylene group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1010867 | 1967-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1239073A true GB1239073A (en:Method) | 1971-07-14 |
Family
ID=4359438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1239073D Expired GB1239073A (en:Method) | 1967-07-13 | 1968-07-09 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US3565778A (en:Method) |
| FR (2) | FR1576004A (en:Method) |
| GB (1) | GB1239073A (en:Method) |
| NL (1) | NL6809924A (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3565778A (en) * | 1967-07-13 | 1971-02-23 | Ciba Geigy Corp | Process for the manufacture of beta-hydroxy-steroid-ketones |
| US3880895A (en) * | 1972-07-21 | 1975-04-29 | American Home Prod | Hydroxylation of d-13-alkyl-17{60 -ethynyl-hydroxygon-4-en-3-one and derivatures thereof |
| DK136729C (da) * | 1974-10-18 | 1978-05-01 | Schering Ag | Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2833794A (en) * | 1957-12-18 | 1958-05-06 | Searle & Co | 3-oxygenated 4-androstene-1, 17-diols and derivatives |
| US3565778A (en) * | 1967-07-13 | 1971-02-23 | Ciba Geigy Corp | Process for the manufacture of beta-hydroxy-steroid-ketones |
-
1968
- 1968-07-09 US US743278A patent/US3565778A/en not_active Expired - Lifetime
- 1968-07-09 GB GB1239073D patent/GB1239073A/en not_active Expired
- 1968-07-11 FR FR1576004D patent/FR1576004A/fr not_active Expired
- 1968-07-12 NL NL6809924A patent/NL6809924A/xx unknown
- 1968-10-10 FR FR169369A patent/FR7851M/fr not_active Expired
-
1970
- 1970-11-13 US US00089527A patent/US3723418A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3723418A (en) | 1973-03-27 |
| NL6809924A (en:Method) | 1969-01-15 |
| US3565778A (en) | 1971-02-23 |
| FR7851M (en:Method) | 1970-04-20 |
| FR1576004A (en:Method) | 1969-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1239073A (en:Method) | ||
| GB1211219A (en) | 21-aldehydes of the pregnane series and derivatives thereof and process for their manufacture | |
| GB1495531A (en) | 11beta-alkyl steroids of the estrane series | |
| GB1158331A (en) | Delta<4,9,11>-Trienes of the 19-Nor-Androstane Series and Process for their manufacture | |
| ES348727A1 (es) | Un procedimiento para preparar esteroides. | |
| GB1164067A (en) | Acetals and Ketals of 3beta-(&alpha-L-rhamnosido)-04beta-hydroxy-19-oxo(or-hydroxy)-bufa-4,20,22-trienolides | |
| GB1248418A (en) | 3-oxo-steroid-oximes and process for their manufacture | |
| GB1231472A (en:Method) | ||
| GB1162769A (en) | Delta<,5>-7alpha-Methyl-Estradienes and their preparation | |
| GB1236474A (en) | 3-oxo-a,19-bis-nor-b-homo-steroid-5(10)-enes and process for their manufacture | |
| GB1339614A (en) | Spiro-steroid-17,2-furan-3-ones- and a process for their manufacture | |
| GB1154120A (en) | 3-Methyl-19-nor-3,5-Androstadien-17beta-ols | |
| GB1164705A (en) | Preparation of Delta<7>-Dehydro Steroids | |
| SE324562B (en:Method) | ||
| GB1282520A (en) | 06-methyl-steroids and processes for their preparation | |
| GB1317093A (en) | 17alpha methylenecyclopropyl- and 17alpha-spiropentyl-steroids and process | |
| GB1324612A (en) | Epoxy estranes processes for their preparation and compositions incorporating them | |
| GB1263383A (en) | 6-fluoro steroids of the androstane series and their manufacture | |
| ES322215A1 (es) | Procedimiento para la preparaciën de composiciones que tienen propiedades progestacionales | |
| GB1131443A (en) | A process for the manufacture of steroids | |
| GB1147656A (en) | New 6ª-methyl-oestrene compounds | |
| GB1151209A (en) | Pentacyclic Steroid Intermediates and Method of Preparing the same | |
| GB1245293A (en) | New halogen-pregnadienes and process for their manufacture | |
| ES388784A1 (es) | Un procedimiento de preparacion de la 17 alfa - hidroxi - pregna - 4,9 (11)-dieno - 3,20 - diona. | |
| GB1308656A (en) | Cardadienolide derivatives and process for their manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |